Contact
Please use this form to send email to PR contact of this press release:
PDS Biotechnology Expands CRADA with the National Cancer Institute to Include Second Versamune®-Based Anti-Cancer Product
TO:
Please use this form to send email to PR contact of this press release:
PDS Biotechnology Expands CRADA with the National Cancer Institute to Include Second Versamune®-Based Anti-Cancer Product
TO: